Stem cell therapies for reversing vision loss
Current clinical trials that evaluate human pluripotent stem cell (hPSC)-based therapies predominantly target treating macular degeneration of the eyes because the eye is an isolated tissue that is naturally weakly immunogenic. Here, we discuss current bioengineering approaches and biomaterial usage...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cell Press
2017
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/63289/1/Stem%20cell%20therapies%20for%20reversing%20vision%20loss.pdf |